Sleep Disorders: Clinical Trials

170 trials for Sleep Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

115 completed, 20 unknown, 10 not yet recruiting, 9 terminated. 74 Not applicable, 21 Phase 3, 16 Phase 4, 10 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable74Completed 51, Unknown 10, Recruiting 4, Terminated 4, Not yet recruiting 3, Withdrawn 2
Phase 321Completed 16, Unknown 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 416Completed 12, Unknown 2, Not yet recruiting 1, Terminated 1
Phase 210Completed 8, Terminated 1, Withdrawn 1
Phase 15Completed 3, Terminated 2
Early Phase 11Completed 1

Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sleep Quality, Caregiver Burden, Stress, and Self-Efficacy in Parents of Children With Spastic Diplegic Cerebral Palsy: A Comparison by Night Orthosis Use
Cerebral Palsy, Sleep Disorders
Not yet recruitingAtılım University1502026-11-012026-10-08
HEARTBEAT SOUND FOR BREASTFEEDİNG DİFFİCULTİES: A RANDOMİZED CONTROLLED TRİAL
Standardized Maternal Heartbeat Sound Application - Sleep, Circadian Rhythm
Not applicableNot yet recruitingHakan Avan802026-10-252026-10-19
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Berobenatide, Placebo - Apnea, Sleep Disorders
Phase 3Not yet recruitingPfizer2582026-10-192026-10-19
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Berobenatide, Placebo - Apnea, Sleep Disorders
Phase 3RecruitingPfizer2582026-09-172026-10-13
Efficacy of CBT-I With Adjuvant Melatonin in Older Adults Chronic Insomnia
Cognitive behavioural therapy for insomnia, Melatonin 3 mg immediate-release, Psychoeducation - Insomnia, Aging
Not applicableRecruitingThe University of Hong Kong1832026-08-012026-08-21
Diaphragmatic Breathing Exercises on Sleep Disorders un Polycystic Ovarian Syndrome
Diaphragmatic breathing exercises, Lifestyle modification advices - Polycystic Ovarian Syndrome (PCOS), Pittsburg Sleep Quality Index
Not applicableRecruitingAdly A Adam542026-07-112026-07-14
Effect of Progressive Muscle Relaxation and Diaphragmatic Breathing on Sleep Disturbances in Chemotherapy Patients
Progressive Muscle Relaxation and Diaphragmatic Breathing - Sleep Disturbance, Sleep Disorders
Not applicableNot yet recruitingCairo University402026-07-012026-06-10
PREDiction of Different Variants of Sleep Stages for the Diagnosis Support of Chronic Insomnia and Epilepsy
Chronic Insomnia, Epilepsy
Not yet recruitingAssistance Publique - Hôpitaux de Paris15002026-06-012026-04-29
Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment
Dexmedetomidine-esketamine combination, Placebo - Older Adults, Cognitive Impairment
Phase 4Not yet recruitingPeking University First Hospital602026-06-012026-06-01
Optimization of Melatonin Administration in Healthy Adults
Mel 2 mg 30 min, Mel 2 mg 3 h, Mel 4 mg 30 min - Sleep Disorders
Not applicableNot yet recruitingIRCCS Fondazione Stella Maris142026-05-012026-04-07
A Longitudinal Follow-Up Study on Predicting Major Depressive Disorder From Rest-Activity Rhythm Profiles
Major Depressive Disorder (MDD), Sleep Disorders
Not yet recruitingChinese University of Hong Kong1602026-02-012026-02-05
Plant Protein With Ashwagandha-Rhodiola for Sleep Quality
Plant Protein Supplement, Rhodiola rosea Extract, Ashwagandha KSM-66 - Sleep Quality, Sleep Disorders
Not applicableCompletedUniversidad Pablo de Olavide1002025-11-012026-03-10
Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers
MMH-450 - Sleep Disorders
Phase 1CompletedMateria Medica Holding182025-08-152026-08-04
An Exploratory Study of Chenghuang Circadian Rhythm Regulator in Subjects With Sleep Disorders
Chenghuang Circadian Rhythm Regulator - Sleep Disorders
Not applicableCompletedShanghai Cell Therapy Group Co.,Ltd152025-06-062026-02-17
Impact of Sleep Disorders and Digital Support on Older People's Health
Sleep Disorders, Frailty
Not yet recruitingUniversity of Parma3002025-05-012025-04-25
Intravascular Laser and Electroacupuncture for Sciatica With Insomnia: A Pilot Trial
Electroacupuncture, Intravascular Low-Level Laser Therapy (ILIB) - Sleep Disorders, Sciatica
Not applicableCompletedLe Hoang Minh Quan662025-04-012026-07-01
Study of Sleep Quality in the Intensive Care Unit and Association with Weaning from Invasive Ventilation in Patients with Chronic Obstructive Bronchopneumopathy.
COPD, COPD Exacerbation
Not yet recruitingUniversity Hospital, Grenoble422025-01-012024-10-23
Electronic Six-Image Pulse Diagnosis for TCM Syndrome Identification in Sleep Disorders
Three-Dimensional Electronic Pulse Diagnosis, Expert Traditional Chinese Medicine Syndrome Differentiation - Sleep Disorders, Traditional Chinese Medicine Syndrome
CompletedSouthern Medical University Hospital of Integrated Traditional Chinese and Western Medicine2012025-01-012026-07-10
Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
No Intervention: Observational Cohort - Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis
RecruitingHeinrich-Heine University, Duesseldorf8372024-11-012026-03-06
Sleep Disturbance and Daytime Fatigue as Predictors of Cognitive Decline and Functional Decline in Chronic Rhinosinusitis
Self-Reported Questionnaires for Sleep, Fatigue, and Quality of Life - Chronic Rhinosinusitis, Sleep Disorders
CompletedSinai University1342024-09-152025-11-21

Showing 20 of 170. Sign in to see all of them.

Narrower conditions

Sleep Wake Disorders (170)  ·  Sleep Initiation and Maintenance Disorders (37)  ·  Fatigue (21)  ·  Depression (16)  ·  Parasomnias (14)  ·  Anxiety Disorders (12)  ·  Sleep Apnea Syndromes (12)  ·  Stress Disorders, Post-Traumatic (10)  ·  Breast Neoplasms (9)  ·  Obesity (7)  ·  Pain (7)  ·  Sleep Apnea, Obstructive (7)  ·  Alzheimer Disease (6)  ·  Disorders of Excessive Somnolence (6)  ·  Mental Disorders (6)

Broader conditions

Pathological Conditions, Signs and Symptoms (170)  ·  Neurologic Manifestations (169)  ·  Signs and Symptoms (169)  ·  Nervous System Diseases (167)  ·  Mental Disorders (164)  ·  Sleep Disorders, Intrinsic (54)  ·  Dyssomnias (53)  ·  Behavior (24)  ·  Respiratory Tract Diseases (23)  ·  Central Nervous System Diseases (20)  ·  Respiration Disorders (20)  ·  Behavioral Symptoms (19)  ·  Brain Diseases (17)  ·  Neurocognitive Disorders (16)  ·  Apnea (15)

Interventions

Melatonin (9)  ·  Zolpidem (8)  ·  Cognitive Behavioral Therapy (6)  ·  Mirtazapine (5)  ·  Therapeutics (5)  ·  Prazosin (4)  ·  Modafinil (3)  ·  Sugars (3)  ·  Control Groups (2)  ·  Dexmedetomidine (2)  ·  Early Intervention, Educational (2)  ·  Exercise (2)  ·  Mass Screening (2)  ·  N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide (2)  ·  Paroxetine (2)

Sponsors

US Department of Veterans Affairs (7)  ·  Brigham and Women's Hospital (4)  ·  GlaxoSmithKline (4)  ·  Merck Sharp & Dohme LLC (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Brasilia University Hospital (3)  ·  Itamar-Medical, Israel (3)  ·  Massachusetts General Hospital (3)  ·  Sanofi (3)  ·  University Hospital, Strasbourg, France (3)  ·  University of Chicago (3)  ·  VA Office of Research and Development (3)  ·  Alliance for Clinical Trials in Oncology (2)  ·  Cairo University (2)  ·  Child Psychopharmacology Institute (2)

Countries

United States (73)  ·  France (12)  ·  Germany (9)  ·  Canada (8)  ·  Brazil (7)  ·  China (7)  ·  Israel (6)  ·  Egypt (4)  ·  Italy (3)  ·  South Korea (3)  ·  Switzerland (3)  ·  Turkey (Türkiye) (3)  ·  Australia (2)  ·  Greece (2)  ·  Hong Kong (2)

Top investigators

Bernard BH Hirschel, Professor (2)  ·  Bill J Duke, M.A., Ph.D. (2)  ·  Dong-Xin Wang, MD, PhD (2)  ·  Kaloyan S Tanev, MD (2)  ·  Mary E. Long, PhD (2)  ·  Michael Kohrman, M.D. (2)  ·  Murray Raskind, MD (2)  ·  Yushiro Yamashita, MD, PhD (2)  ·  Ahmed M Othman, Professor (1)  ·  Amit Sood, MD (1)

Results publications

PMID 33189083, PMID 32351205, PMID 41170811, PMID 11820554, PMID 12382454, PMID 15172206, PMID 16126650, PMID 16137280, PMID 16399214, PMID 17069768, PMID 17868655, PMID 18052566, PMID 18583104, PMID 18673165, PMID 20051221, PMID 20357383, PMID 21219521, PMID 21399726, PMID 21450184, PMID 22172964, PMID 22232085, PMID 22617164, PMID 22878784, PMID 23024438, PMID 23834036, PMID 23846759, PMID 23929523, PMID 23940231, PMID 24024727, PMID 24090266, PMID 24107292, PMID 24495406, PMID 25182079, PMID 25300874, PMID 25317085, PMID 25945597, PMID 26200520, PMID 26262586, PMID 26285003, PMID 26411693, PMID 26414990, PMID 26435889, PMID 27039928, PMID 27092785, PMID 27197271, PMID 27320368, PMID 27450632, PMID 27931249, PMID 28110112, PMID 28111555

NIH funding

U10CA081851 (2), 2008 (1), K23RR020783 (1), M01RR000865 (1), P01AG020677 (1), P20AA017839 (1), P30CA006973 (1), P30CA015083 (1), P30CA068485 (1), R01HL062252 (1), R01MH024652 (1), R01MH053575 (1), R01NR016191 (1), R21AT002713 (1), R25HL116378 (1)